The Swiss pharmaceutical group Novartis is reaching for the biotech company Morphosys. The Swiss are putting 2.7 billion euros on the table. Novartis is particularly interested in the promising drug.
Puma SE shares fell to their lowest level since October 2018 on Wednesday after key figures for 2023 and the outlook for 2024. With a discount of 6.6 percent to 40.16 euros, they were at the bottom of.
Puma shares slumped to their lowest level in almost six years on Wednesday after key data for 2023 and the outlook for 2024. With a final discount of 10.5 percent to 38.49 euros, they were the clear.
The shares of Porsche AG slumped to a record low on Friday after the publication of sales figures for the past year. Weak sales in China had a negative impact and also weighed on the entire European.
Commercial kitchen equipment supplier Rational performed better than expected last year thanks to a strong final quarter. The company posted record figures for sales and operating profit. Growth came.